Loading...
XNAS
CYRX
Market cap769mUSD
Jul 09, Last price  
15.72USD
1D
3.01%
1Q
62.56%
Jan 2017
385.19%
IPO
496.70%
Name

Cryoport Inc

Chart & Performance

D1W1MN
XNAS:CYRX chart
P/E
10.12
P/S
4.50
EPS
1.55
Div Yield, %
Shrs. gr., 5y
5.35%
Rev. gr., 5y
17.49%
Revenues
176m
-24.47%
67,10383,56435,124117,956475,504555,6371,100,5392,659,9433,935,3205,882,1997,678,81611,954,26719,626,45333,942,00078,696,000222,608,000222,608,000237,277,000233,255,000176,177,000
Net income
78m
P
-2,326,259-4,564,054-16,705,151-5,651,561-6,152,278-7,832,928-6,382,433-19,565,426-7,026,913-9,820,364-13,113,220-7,899,000-9,555,601-18,332,000-32,693,000-275,528,000-275,528,000-37,333,000-99,587,00078,301,000
CFO
-9m
L-47.44%
-710,259-1,820,250-2,586,470-2,853,359-4,811,411-6,780,134-4,785,144-4,380,659-4,127,702-6,305,690-5,718,876-3,583,126-3,352,380-1,324,000-14,866,0008,126,000-1,851,000-757,000-16,323,000-8,580,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.
IPO date
Jul 24, 2015
Employees
1,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT